Week 476 Review - Dreadful week for all microbiome shares widens deficit.

A mixed week with some big risers and fallers, but a dreadful week for all my microbiome shares led to a widening in the deficit between cost and value of £4,951 to £120,218 and the deficit between injection and amount and value grew to £52,014. Total portfolio value dropped to £108,413.

SBTX:SkinBioTherapeutics plummeted 16%, PBX:Probiotix Health dropped a similar 13% and OPTI:Optibiotix dropped 8%, so looks like the microbiome is well out of favour. It could also be that there's no demonstrable progress from any of the companies.

GSK:GSK has been utterly rubbish lately and dropped 6% this week, which is a lot for a big global company.

IGG:IG Group has been on a really good run, but gave up 6% of recent gains this week. They are still up by 10% though.

ALU:Alumasc Group continue to impress, with a 6% rise taking them to 46% up in a very short amount of time.

ASHM:Ashmore Group have been realy struggling, but climbed 8% this week. They are still 28% down though.

Share of the Week is CORE:Solidcore Resources, which finally reacted to the increase in gold prices and went up by 10%. This puts them 83% down, but I can start reporting on them again. I still await their London re-listing now all ties with Russia are gone.

Here's the ISA and shares portfolio after week 8 of year 10.

			Weekly Change
Cash	£23.24		-£4.56
Portfolio cost	£111,188.18		+£0
Portfolio sell value (bid price-commission)	£46,369.53	(-58.3%)	-£3,137.13
Potential profits	£0		+£0
Yr 10 Dividends	£0		+£0
Yr 10 Interest	£0.11		+£0
Yr 10 Profit from sales	£149.75		+£0
Yr 10 proj avg monthly profit	£72.09	(1.1%)	-£13.13
Total Dividends	£12,222.49		+£0
Total Interest	£6.91		+£0
Total Profit from sales	£18,027.59		+£0
Average monthly cash profit	£271.04	(4.0%)	-£0.61
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	36%		+0%

Very little happened other than the portfolio value dropping horribly. The drop in cash was partly monthly fees and partly doing a cross-check to the actual accounts. Not sure where I lost 81p, but it's probably an AJ Bell fee.

Looks better than it really is

Looks as bad as it really is

The SIPP looks like this after week 460 overall and week 44 of year 9.

			Weekly Change
Cash	£221.79		+£18.58
Portfolio cost	£115,062.19		+£0
Portfolio sell value (bid price - commission)	£60,623.61	(-47.3%)	-£1,754.45
Potential profits	£4,931.32		+£402.77
Yr 9 Dividends	£978.58		+£21.21
Yr 9 Interest	£4.98		+£0
Yr 9 Profit from sales	£5,670.64		+£0
Yr 9 proj avg monthly profit	£636.84	(10.0%)	-£12.94
Total Dividends	£15,613.46		+£21.21
Total Interest	£10.91		+£0
Total Profit from sales	£16,506.54		+£0
Average monthly cash profit	£290.01	(4.6%)	-£0.46
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	40%		+0%

I got £7 dividend from ATYM:Atalaya Mining, £2 from my miniscule holding in FOUR:4imprint and £11 from GAW:Games Workshop. Potential profits went up £402 thanks to my gold miners and magic formula shares, but portfolio value dropped significantly. I want to lose my microbiome shares from the SIPP but need them to increase by quite a lot before I'm prepared to sell.

Getting quite a long way from the injection line after coming so close a few months back.

Even this account has dropped below the trend line.

The trading account looks like this after week 426 overall and week 10 of year 9.

			Weekly Change
Cash	£63.39		+£0
Portfolio cost	£2,073.87		+£0
Portfolio sell value (bid price - commission)	£1,112.28	(-46.4%)	-£71.96
Potential profits	£0		+£0
Year 9 Dividends	£0		+£0
Year 9 Interest	£0		+£0
Year 9 Profit	£0		+£0
Yr 8 proj avg monthly profit	£0	(+0%)	+£0
Dividends	£85.46		+£0
Interest	£0.03		+£0
Profit from sales	-£602.54		+£0
Average monthly cash profit	-£5.26	(-3.0%)	+£0.01
(Sold stocks profit + Dividends - Fees / Months)

What can I say - everything fell.

A progressive failure for around 4 months

I'm amazed the trend line is still pointing upwards.

I'm 3 weeks late writing this. The next 2 weeks don't get any better...